INDO-TURKISH TRADE On the rise

 

A

According to Adnan Yildirim (right), deputy minister of econ­omy, Turkey, trade between India and Turkey is expected to rise three­fold from $7.49 billion in 2014 to over $22 billion in the next 5-7 years, sup­ported by a “favourable business cli­mate in both the countries”. He was speaking at the Turkey-India Busi­ness Forum, jointly organised by the MVIRDC World Trade Centre, the All India Association of Industries (AIAI), ministry of economy, Republic of Turkey, Turkish Exporters Assembly and Aegean Exporters’ Associations. It was Yildirim’s first visit to India, and he chose to bring his delegation to Mumbai first as it is the financial capital and that his visit would be successful in bringing about fruitful collaborations.

On the cards for the two coun­tries is the talks on the proposed FTA. Yildirim was hopeful that the vol­ume of the intra-Asian trade would rise significantly from the present level of $3.08 trillion, if Indo-Turk- ish bilateral trade gains momentum. “The recent international develop­ments like falling crude oil prices, recovering US economy augur well for the economic growth of these two countries and I am hopeful that this would lead to a sustainable bilateral trade,” he said.

Indian expectations Turkey, which ranks 17 in size among all economies in the world, aims to improve its posi­tion to 10 by 2023. “Our economy, which grew 2.9 per cent in 2014, is expected to grow 4 per cent in 2015 and 5 per cent the following year,” said Serdar Akinci, head of depart­ment, ministry of economy, Turkey. He gave an overview of the emerg­ing macroeconomic trends in Turkey and listed the investment incentives provided by the Turkish govern­ment. Shedding light on the expand­ing Turkish trade, Akinci said that the total trade volume of the country would rise from $400 billion in 2014 to $464 billion in 2015 and further to $500 billion by 2017. He expected

 

Kalantri and Yildirim: fruitful collaboration

 

 

a large share of this increase in trade to come from India.

Vijay Kalantri, vice-chairman, MVIRDC World Trade Centre, and president, AIAI, assured the Turk­ish delegation that his organisations would pursue the FTA with the Indian government and added that it was an opportune time for both the coun­tries to explore business opportuni­ties with each other; Turkey could act as a hub for India’s investment in the European continent, North Africa and the Middle East.

According to Riza Seyyar, chair­man, Aegean Fresh Fruit and Vege­tables Exporter’s Association, which represents 60,000 exporters in Tur­key, while India exports $6.9 billion worth of goods to Turkey, it imports only $590 million worth. He sug­gested the Indian government and businessmen use Turkey as a gateway to access European markets.

Amongst the key sectors that the Turkish delegation had prioritised for its visit to India, which included pharma, test facilities, mining, edu­cation, energy, carbon fibre and high technology, the focus area was tour­ism infrastructure, namely encour­aging Indian capitalists to invest in the sector. Turkey expects an inflow of 50 million tourists with a revenue of $50 billion in this financial year.

Although over 150 Indian compa­nies have trade investments in Tur­key, investment from Turkey is much lower, which needs to be raised in view of ‘Make in India’, ‘Digital India’ and the government’s intent on ease of doing business.  ♦

feedback@businessindiagroup.com

CONFERENCES

Humbug no more

I

In a series of dramatic developments that could have a far-reaching impact on medicine and healthcare, over 25 global scientists have show­cased a possible homeopathic cure for dreaded diseases like cancer, hiv, TB and malaria at a two-day world homeopathy summit. They have established beyond a doubt that this stream of medicine is not humbug, but a ‘real science’.

Numerous studies presented by scientists from Brazil, Italy, as well as researchers from ICMR, IIT B, ICT, IICT, Haffkine and CSIR, among oth­ers, proved that homeopathic medi­cines contain nano-particles – which surprised even homeo practitioners, who were under the impression that the energy substance involved in this mode of treatment was unknown, says Dr Rajesh Shah, organising sec­retary of the summit, hosted by the Global Homeopathy Founda­tion (GHF), in collaboration with the Central Council for Research in Homeopathy (CCRH).

“Three issues were fundamental to homeopathy – was it a medicine, does it have any effect and does it offer a cure?” explains Shah, a senior homeo­path. “And, lack of proper answers to these questions give rise to myths that it is a medicine without medicine and has only a placebo effect.” The World Summit seriously addressed these issues, “And, I must say, the 1,000-plus delegates were simply baffled by the results of research shared by over 25 speakers from all across the world.”

Scientists Jayesh Bellare (iit B) anc I Rajendran, using the facilities avail­able at the centre for nano-science & engineering (ceNSE), use, Bangalore have established that homeo med: cines contain nano-particles, whic: can be viewed under a high-resolu-1 tion transmission electron microscope I (HRTEM), and also using energy dispe:-l sive spectroscopy (EDS). Dr P.K. Josh. I physicist, Tata Institute of Fundamer I tal Research (TIFR), demonstrated tf I the ultra-diluted homeo medicir I could be traced with the help of laser beams in a laboratory. In the light of these eye-openers, homeopathy is now viewed as nano-pharmacolog­ical medicine, and not some obscure method of prescription.

Rajendran has demonstrated that quantum dots detected in homeo­pathic ultra-dilutions are capable of moving in cellular and sub-cellular levels like RNA and DNA and that they have epigenetic capabilities to influ­ence even the genetic materials, which could be the most probable reason for the curative effect of homeopathic high dilutions. The nano-particle- based homeopathic medicines have shown to be capable of altering the course of diseases such as malaria, cancer, haemophilia, arthritis, and allergies, in various studies by differ­ent scientists.

Breakthrough A breakthrough research by a zoologist Upama Bagai, of Punjab University, on blood sam­ples of rats infected with malaria, showed a drastic reduction of the germs after the administration of homeopathic medicines China Offi­cinalis and Chelidonium, in 30c potencies – the highly diluted and potentised homeopathic prepara­tions from plant extracts. Another study by Shah himself and Sadhana Sathaye, assistant professor, Institute of Chemical Technology, Mumbai, has proved that homeopathic medi­cines are as effective as anti-inflam­matory Diclofenac in rats.

Molecular biologist Gaurisankar, professor, Bose Institute, Kolkata, demonstrated that cancerous tumours regressed significantly after the administration of homeopathic nano­particles of Calcaria Carbonicum. In an observational study conducted among 30 HIV-infected patients, Shah and his team also found that, follow­ing the administration of a homeo­pathic medicine derived from the human immune-deficiency virus, the viral load itself reduced, while fighter CD 4 cells increased and weight and appetite improved in some of the patients. Shah’s paper on this sub­ject has recently been published in the CCRH journal. A. H. Bandivdekar, an eminent scientist working on HIV

 

Shah: three fundamentals

 

 

at NIIRH, felt that this research was indeed encouraging.

Studies by Kanjaksha Ghosh, director, National Institute of Immu- no-haematology, in association with fellow researcher Tapas Kundu, dem­onstrated that acute bleeding in hae­mophilia patients could be treated with homeopathic medicines. “As against an annual expenditure of over ?1 lakh on conventional medicines, the homeopathic medicine would cost just about ?4,000,” informed Kundu at the summit.

All these and other recent research has created adequate evidence for the efficacy of homeopathic medicines, said Arun Jamkar, a cancer surgeon and vice-chancellor, Maharashtra University of Health Sciences (MUHS), in his keynote address. He opined that homeopathy and conventional medicine could be integrated to ben­efit patients.

Paolo Bellavite, molecular sci­entist from Italy and A.R. Khuda- Bukhsh from Kalyani, proposed a working model of the mechanism of action of homeopathic medicines. Khuda-Buksh has worked on homeo­pathic research for over 30 years and has published probably the world’s highest number of homeopathy research articles (over 100) in peer- reviewed journals.

“Work done by Bellavite and Khu- da-Bukhsh has answered the third fundamental question, relating to the mechanism of action of homeopathic medicine,” said Sreevals Menon, managing trustee, Global Homeopa­thy Foundation, Kochi. “After switch­ing from energy medicine to material medicine, homeopathy will take a big leap in research, as observed in the work of many scientists at the conference.”

Proving the efficacy of homeop­athy, Elio Rossi, director, Campo di Marte Hospital, Lucca, Italy, a large homeopathic clinic, shared a paper on the proven efficacy of homeopathy in 1,400 patients suffering from aller­gic and skin diseases. Leoni Villano Bonamin from Paulista University, Brazil, presented a study demonstrat­ing the effect of homeopathy against parasite disease Leishmaniasis in the laboratory as well as on human body.

Studies conducted at Indian Insti­tute of Chemical Technology (1ICT), Hyderabad, showed that snake venom, transformed into a homeopathic med­icine, could reduce the growth of HIV virus by inhibiting RT (reverse tran­scriptase), an enzyme required for the multiplication of the deadly HIV, Hep­atitis C and Ebola viruses. Praveen Kumar and Prathama felt that this research would open new ways to treat HIV and other such diseases, including Ebola.

Khuda-Bukhsh’s study has revealed that genotoxic effects of arsenic triox­ide poisoning can be treated with suc­cess using potentised arsenic metal, proving the fundamental principle of homeopathy, which says that like can be cured by like, if administered in extremely small doses. Similarly, he further demonstrated that toxic­ity of mercury, cadmium and tin can also be reduced by homeopathic med­icines prepared from the same metals. “Treatment of toxicity is another area which could be addressed by home­opathy,” observed Eswara Das, chair­man, GHF & former advisor, Ayush.

GHF, founded by a group of homeo­pathic activists with a mission to spread the benefits of homeopathy to the masses across the world, is a non-government, non-profit making group and organised the summit that has contributed towards a change in perspectives. “GHF now looks forward to spreading the knowledge it has obtained at the summit worldwide,” concluded Sreevals Menon, the man­aging trustee of the NGO.

♦ LANCELOT JOSEPH feedback@businessindiagroup.com

Leave a Reply

Your email address will not be published. Required fields are marked *